Bildnachweis: Sunriseforever – pixabay.
In our new Impact Life Sciences special edition, we take a closer look at the dynamic development of the biotechnology and life sciences sector in Germany, Europe and around the world.
New technologies are fundamentally reshaping the life sciences value chain: artificial intelligence is accelerating research and development, biotechnology is opening up new therapeutic approaches, and radiotheranostics is gaining momentum. At the same time, global flows of innovation and capital are shifting.
For Europe, this is about more than scientific excellence: How can research be translated into scalable businesses – and how can technological strength be turned into economic sovereignty?
Highlights of the special edition
- We speak to Federal Research Minister Dorothee Bär about the future of research and technology.
- Carsten Maschmeyer shares his perspective on what Europe needs to become a global life sciences champion.
- We look at international developments – from Saudi-Arabia to China.
- And we explore the role of AI, biotechnology, personalised medicine and new platform technologies in shaping the next generation of life sciences companies.
Plus: exciting start-ups, investors and ecosystems, emerging technologies, and the question of where capital and innovation are heading.
Our new “Impact Life Sciences” special edition is now available online!
Partners of the special issue include itm, KAIMRC, NRW.Bank, start2grow and YPOG!
